Are Wearables Worthy for Regulated Clinical Trials?

Watch the on-demand webinar today!

Industry Experts Bust the Myths of 'Validation'

Covid-19 and the imminent rise of 5G networks are an accelerant to advancing wearables for clinical trials, deepening our commitment to tracking better digital endpoints.

But in our collective rush to run trials virtually, we must validate that the new devices and wearable solutions are appropriate and accurate. In this webinar, lead scientists and industry leaders share essential guidelines to start with the end in mind and take a comprehensive approach to managing complexity, including:

  • Key differences between standard COA validation and sensor validation
  • Nuances of verification, analytical validation, and clinical validation of a wearable measure
  • Why fundamentals should be in place before deploying AI and ML
  • Best practice implementation that maximizes the value of your data

Fill out the form to watch the webinar and learn the importance of these guidelines and how best practice implementation will maximize the value of your data in the long term.

View the Webinar

Webinar Panelists

ariel_dowling

Ariel Dowling
Director, Digital Strategy
Takeda

Abhi Verma - Novarits

Abhi Verma
VP, Lead
Applied Technology Innovation
Novartis

Kate Lyde, PhD.

Kate Lyden
Chief Science Officer
VivoSense

jeremy_wyatt

Jeremy Wyatt
CEO
ActiGraph